Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amyloid Deposition and Preexisting Vulnerable Carotid Plaque Features Predicting Cognitive Improvement After Surgery
NCT03068442Phase 2Active, not recruiting
- Start
- Feb 2017
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flutemetamol in carotid atheroma (CAS), inflammation. Started Feb 2017; status: active, not recruiting.
02
Drugs
flutemetamol
03
Conditions
carotid atheroma (CAS)inflammation
Beyond the preview
Go deeper on NCT03068442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068442.